Improving Speed-to-Market and Speed-to-Access With AI-Powered Procurement

Here’s a sneak peek from the webinar to help you decide

In biopharma, the need for speed is ongoing. Organizations aim to get their assets discovered, approved, commercialized, and in the hands of patients as fast as safely possible –but there’s one type of delay that can upend timelines in unexpected ways: procurement. Present in the end-to-end journey of drug development, procurement complexities are an inherent – but not always well-predicted or understood – concern from bench to clinical to commercial stages. Without a cohesive procurement strategy, critical tasks are often prone to disorganization, stakeholder frustrations, and costly oversights.

But what if there were a way to preempt those pains with an AI-powered approach? In this webinar, join experts from ORO Labs as they walk through emerging opportunities for biopharma leaders to operationalize and overcome procurement challenges through new trends in so-called “procurement orchestration.” You’ll learn:

• How biopharma leaders are applying orchestration principles to their procurement strategies for faster speed-to-market and speed-to-access
• Best practices to predict and preempt procurement delays and challenges across processes, systems, people, and data
• New technologies that are accelerating and automating procurement workflows with an orchestrated approach
• What to look for, and questions to ask, when assessing procurement orchestration solutions

In this webinar, hear from:

• Jennifer Sadr, Head of Customer Success, ORO Labs
• Andy Shigo, Head of Procurement, Iovance Biotherapeutics